ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,432Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 337

$635K Total Retail Price of All Prescriptions

Rank: 39 out of 337

482 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 482 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 482 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 12,146 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
AMLODIPINE BESYLATE 570 545 1 3
LISINOPRIL 547 523 2 2
SIMVASTATIN 544 496 3 1
WARFARIN SODIUM 531 517 4 11
LEVOTHYROXINE SODIUM 528 477 5 5
METOPROLOL TARTRATE 498 487 6 6
FUROSEMIDE 365 349 7 8
OMEPRAZOLE 346 284 8 4
SERTRALINE HCL 342 339 9 18
LOSARTAN POTASSIUM 325 321 10 15
DONEPEZIL HCL 259 258 11 22
HYDROCHLOROTHIAZIDE 243 212 12 9
ATORVASTATIN CALCIUM 237 222 13 7
TRAZODONE HCL 234 227 14 16
METFORMIN HCL 194 150 15 12
CITALOPRAM HBR 180 171 16 17
SYNTHROID 180 167 16 41
MIRTAZAPINE 162 153 18 27
TRAMADOL HCL 158 158 19 32
PRAVASTATIN SODIUM 152 126 20 14
NAMENDA 151 151 21 35
PANTOPRAZOLE SODIUM 148 138 22 36
ATENOLOL 146 125 23 10
GABAPENTIN 143 130 24 20
GLIMEPIRIDE 137 112 25 55
RANITIDINE HCL 111 84 26 30
ALENDRONATE SODIUM 101 101 27 19
FENOFIBRATE 101 92 27 48
BISOPROLOL FUMARATE 100 99 29 67
LOSARTAN-HYDROCHLOROTHIAZIDE 96 83 30 60
CYMBALTA 91 49 31 59
DIOVAN 90 90 32 26
LOVASTATIN 90 90 32 24
ESCITALOPRAM OXALATE 87 87 34 66
ENALAPRIL MALEATE 86 83 35 37
HYDROCODONE-ACETAMINOPHEN 85 54 S3 36 13
ZOLPIDEM TARTRATE 84 60 37 23
METOPROLOL SUCCINATE 79 79 38 21
LIDODERM 77 59 39 82
MELOXICAM 76 49 40 54
DIGOXIN 75 75 41 58
HYDRALAZINE HCL 75 75 41 122
PAROXETINE HCL 73 64 43 46
PREDNISONE 71 71 44 40
LIPITOR 70 70 45 33
LEVOFLOXACIN 69 64 46 93
RISPERIDONE 67 67 47 72
QUINAPRIL HCL 64 64 48 50
PROCRIT 61 61 49 214
BISOPROLOL-HYDROCHLOROTHIAZIDE 59 37 50 95
CLOPIDOGREL 59 59 50 42
ADVAIR DISKUS 56 41 52 44
TAMIFLU 56 53 52 147
TAMSULOSIN HCL 54 54 54 25
BENAZEPRIL HCL 54 54 54 109
COLCRYS 53 53 56 128
GLIPIZIDE XL 53 32 56 123
CIPROFLOXACIN HCL 52 47 58 71
LANTUS 52 52 58 49
PLAVIX 51 51 60 74
AZITHROMYCIN 51 45 60 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 26, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.